eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin and General Corporate Update Portfolio News / Karina Tin January 5, 2023 eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin and General Corporate Update Read More »
Remix Therapeutics Appoints Christopher Bowden, M.D., as Chief Medical Officer Portfolio News / Karina Tin January 5, 2023 Remix Therapeutics Appoints Christopher Bowden, M.D., as Chief Medical Officer Read More »